Skip to Main Content

Author Details

Mark W Kieran
Boston Children's Hospital and Harvard Medical School
1982
270
76
PMIDPaper TitleJournal TitlePublished Year
37969032The 8th International RASopathies Symposium: Expanding research and care practice through global collaboration and advocacy.Am J Med Genet A2024
37969032The 8th International RASopathies Symposium: Expanding research and care practice through global collaboration and advocacy.Am J Med Genet A2024
36780194ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma.Clin Cancer Res2023
36780194ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma.Clin Cancer Res2023
36919608Plasma Progerin in Patients With Hutchinson-Gilford Progeria Syndrome: Immunoassay Development and Clinical Evaluation.Circulation2023
37493630Predictive value of micro-RNA expression profiling in pediatric desmoid fibromatosis.Acta Oncol2023
37493630Predictive value of micro-RNA expression profiling in pediatric desmoid fibromatosis.Acta Oncol2023
36919608Plasma Progerin in Patients With Hutchinson-Gilford Progeria Syndrome: Immunoassay Development and Clinical Evaluation.Circulation2023
35105861PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation.Nat Commun2022
35947814The Critical Role of Academic Clinical Trials in Pediatric Cancer Drug Approvals: Design, Conduct, and Fit for Purpose Data for Positive Regulatory Decisions.J Clin Oncol2022
35624227Notch signaling in malignant gliomas: supporting tumor growth and the vascular environment.Cancer Metastasis Rev2022
35552452Characteristics of children ⿤36 months of age with DIPG: A report from the international DIPG registry.Neuro Oncol2022
35788723Structural variants shape driver combinations and outcomes in pediatric high-grade glioma.Nat Cancer2022
35918506An international study evaluating the epidemiology of intracranial germ cell tumors in the native versus immigrant Japanese populations: the need for an international registry.J Neurooncol2022
36479060Diagnostics and prospective outcome of a diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters after surgical resection (DGONC): a case report.Neurooncol Adv2022
35290915ACCELERATE - Five years accelerating cancer drug development for children and adolescents.Eur J Cancer2022
35121998The current landscape of immunotherapy for pediatric brain tumors.Nat Cancer2022
35105861PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation.Nat Commun2022
35788723Structural variants shape driver combinations and outcomes in pediatric high-grade glioma.Nat Cancer2022
35624227Notch signaling in malignant gliomas: supporting tumor growth and the vascular environment.Cancer Metastasis Rev2022
35552452Characteristics of children ⿤36 months of age with DIPG: A report from the international DIPG registry.Neuro Oncol2022
36479060Diagnostics and prospective outcome of a diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters after surgical resection (DGONC): a case report.Neurooncol Adv2022
35947814The Critical Role of Academic Clinical Trials in Pediatric Cancer Drug Approvals: Design, Conduct, and Fit for Purpose Data for Positive Regulatory Decisions.J Clin Oncol2022
35918506An international study evaluating the epidemiology of intracranial germ cell tumors in the native versus immigrant Japanese populations: the need for an international registry.J Neurooncol2022
35290915ACCELERATE - Five years accelerating cancer drug development for children and adolescents.Eur J Cancer2022
35121998The current landscape of immunotherapy for pediatric brain tumors.Nat Cancer2022
33336845Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children.Pediatr Blood Cancer2021
33860611A global approach to long-term follow-up of targeted and immune-based therapy in childhood and adolescence.Pediatr Blood Cancer2021
33585982Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1).Acta Neuropathol2021
33735109The progeria research foundation 10<sup>th</sup> international scientific workshop; researching possibilities, ExTENding lives - webinar version scientific summary.Aging (Albany NY)2021
33601323Bromodomain and extra-terminal inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE.Eur J Cancer2021
33140540A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma.Pediatr Blood Cancer2021
33336845Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children.Pediatr Blood Cancer2021
33601323Bromodomain and extra-terminal inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE.Eur J Cancer2021
33735109The progeria research foundation 10<sup>th</sup> international scientific workshop; researching possibilities, ExTENding lives - webinar version scientific summary.Aging (Albany NY)2021
33585982Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1).Acta Neuropathol2021
33860611A global approach to long-term follow-up of targeted and immune-based therapy in childhood and adolescence.Pediatr Blood Cancer2021
33140540A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma.Pediatr Blood Cancer2021
31233466Outcome of Children Treated for Infantile Hepatic Hemangioendothelioma.J Pediatr Hematol Oncol2020
32236425A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study.Neuro Oncol2020
31986450ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients.Eur J Cancer2020
32381545MR Imaging Correlates for Molecular and Mutational Analyses in Children with Diffuse Intrinsic Pontine Glioma.AJNR Am J Neuroradiol2020
32992153Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.Eur J Cancer2020
32801214Resolution of eicosanoid/cytokine storm prevents carcinogen and inflammation-initiated hepatocellular cancer progression.Proc Natl Acad Sci U S A2020
32688206Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.Eur J Cancer2020
32558190Pediatric cancer research: Surviving COVID-19.Pediatr Blood Cancer2020
31233466Outcome of Children Treated for Infantile Hepatic Hemangioendothelioma.J Pediatr Hematol Oncol2020
31292757Sixty years single institutional experience with pediatric craniopharyngioma: between the past and the future.Childs Nerv Syst2020
31986450ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients.Eur J Cancer2020
32688206Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.Eur J Cancer2020
  • 1 - 50 of 540

Recommended Authors

Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2016
Number of shared co-authors 40
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 1
Nationwide Children's Hospital and The Ohio State University
Career Start Year 2013
Number of shared co-authors 19
Texas Children's Cancer Center, Baylor College of Medicine
Career Start Year 2012
Number of shared co-authors 44
Institute for Genomic Medicine, Nationwide Children's Hospital
Career Start Year 2011
Number of shared co-authors 2
Ohio State University College of Medicine/Nationwide Children's Hospital
Career Start Year 2011
Number of shared co-authors 6
The Chinese University of Hong Kong, Prince of Wales Hospital
Career Start Year 2010
Number of shared co-authors 66
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Career Start Year 2008
Number of shared co-authors 82
Texas Children's Cancer Center, Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 38
Children's Hospital of Philadelphia
Career Start Year 2008
Number of shared co-authors 37
Oregon Health & Science University
Career Start Year 2007
Number of shared co-authors 30
Stanford University
Career Start Year 2006
Number of shared co-authors 58
MacKay Memorial Hospital
Career Start Year 2003
Number of shared co-authors 16
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 2002
Number of shared co-authors 20
University of California los angeles
Career Start Year 2001
Number of shared co-authors 10
McMaster University
Career Start Year 2001
Number of shared co-authors 28
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 73
British Columbia Children's Hospital, The University of British Columbia
Career Start Year 1998
Number of shared co-authors 13
Vanderbilt University Medical Center
Career Start Year 1998
Number of shared co-authors 8
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 8
NYU Grossman School of Medicine
Career Start Year 1995
Number of shared co-authors 21
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1994
Number of shared co-authors 41
Huntsman Cancer Institute, University of Utah
Career Start Year 1990
Number of shared co-authors 53
Meyer Cancer Center
Career Start Year 1990
Number of shared co-authors 20
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1988
Number of shared co-authors 70
Saitama Medical University International Medical Center
Career Start Year 1986
Number of shared co-authors 17
Children's Hospital at Montefiore.
Career Start Year 1986
Number of shared co-authors 17
MD Anderson Cancer Center
Career Start Year 1978
Number of shared co-authors 24
University of California San Francisco
Career Start Year 1974
Number of shared co-authors 15
University of Texas M.D. Anderson Cancer Center
Career Start Year 1974
Number of shared co-authors 27

Collaborators

Co-authored papers 43
Co-authored papers 31
Brain Tumor Institute, Children's National Hospital
Co-authored papers 28
Co-authored papers 25
Co-authored papers 23
Co-authored papers 21
Co-authored papers 20
Co-authored papers 17
Co-authored papers 17
Harvard Medical School
Co-authored papers 15
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 15
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 13
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 13
Co-authored papers 11
University of Pittsburgh School of Medicine
Co-authored papers 11
Co-authored papers 11
The Hospital for Sick Children
Co-authored papers 11
Co-authored papers 10
Co-authored papers 10
Co-authored papers 10
Co-authored papers 9
Co-authored papers 9
Co-authored papers 9
Co-authored papers 9
The Hospital for Sick Children
Co-authored papers 8
Co-authored papers 8
Co-authored papers 8
University of Texas Southwestern Medical School
Co-authored papers 8
Co-authored papers 8
Co-authored papers 8